IL145768A0 - Drinkable pharmaceutical solution - Google Patents

Drinkable pharmaceutical solution

Info

Publication number
IL145768A0
IL145768A0 IL14576800A IL14576800A IL145768A0 IL 145768 A0 IL145768 A0 IL 145768A0 IL 14576800 A IL14576800 A IL 14576800A IL 14576800 A IL14576800 A IL 14576800A IL 145768 A0 IL145768 A0 IL 145768A0
Authority
IL
Israel
Prior art keywords
pharmaceutical solution
drinkable pharmaceutical
drinkable
solution
pharmaceutical
Prior art date
Application number
IL14576800A
Original Assignee
Prod Ethiques Ethypharm Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prod Ethiques Ethypharm Sa Lab filed Critical Prod Ethiques Ethypharm Sa Lab
Publication of IL145768A0 publication Critical patent/IL145768A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04Amoebicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14576800A 1999-04-06 2000-04-06 Drinkable pharmaceutical solution IL145768A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904251A FR2791888B1 (en) 1999-04-06 1999-04-06 ORAL PHARMACEUTICAL SUSPENSION
PCT/FR2000/000870 WO2000059468A1 (en) 1999-04-06 2000-04-06 Drinkable pharmaceutical solution

Publications (1)

Publication Number Publication Date
IL145768A0 true IL145768A0 (en) 2002-07-25

Family

ID=9544041

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14576800A IL145768A0 (en) 1999-04-06 2000-04-06 Drinkable pharmaceutical solution

Country Status (9)

Country Link
EP (1) EP1165043A1 (en)
CN (1) CN1351488A (en)
AU (1) AU778364B2 (en)
BR (1) BR0009551A (en)
FR (1) FR2791888B1 (en)
HU (1) HUP0200711A3 (en)
IL (1) IL145768A0 (en)
WO (1) WO2000059468A1 (en)
ZA (2) ZA200108116B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323264T3 (en) * 2001-08-01 2009-07-10 Novartis Ag COMPOSITION FOR MASK OF FLAVOR.
US7300670B2 (en) * 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
KR20190026962A (en) 2014-09-05 2019-03-13 심바이오믹스 세러퓨틱스 엘엘씨 Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
DE3900811A1 (en) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh NEW MEDICINE
IE902829A1 (en) * 1989-08-14 1991-02-27 Eurand America Microencapsulated taste-masked water-insoluble nsaid drug¹materials
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine coatings for taste-masking orally administrable medicaments
BR9505962A (en) * 1994-12-21 1997-12-23 Johnson & Johnson Aqueous pharmaceutical suspension and process for its preparation
JPH11504940A (en) * 1995-05-09 1999-05-11 ザ、プロクター、エンド、ギャンブル、カンパニー Bismuth and one or more antimicrobial-containing compositions for the treatment and prevention of gastrointestinal disorders

Also Published As

Publication number Publication date
FR2791888B1 (en) 2004-10-08
WO2000059468A1 (en) 2000-10-12
HUP0200711A3 (en) 2003-04-28
AU3825200A (en) 2000-10-23
AU778364B2 (en) 2004-12-02
BR0009551A (en) 2002-05-28
FR2791888A1 (en) 2000-10-13
EP1165043A1 (en) 2002-01-02
HUP0200711A2 (en) 2002-07-29
ZA200108116B (en) 2002-09-25
ZA200108206B (en) 2002-12-24
CN1351488A (en) 2002-05-29

Similar Documents

Publication Publication Date Title
AU139422S (en) Bottle
PL351686A1 (en) Novel pharmaceutical
HUP0203585A3 (en) Pharmaceutical combinations
EG23858A (en) Drug combination
IL145632A0 (en) Pharmaceutical compounds
EG23937A (en) Novel pharmaceutical
GB9916434D0 (en) Pharmaceutical compounds
GB9909041D0 (en) Novel pharmaceutical
GB9914255D0 (en) Pharmaceutical compounds
IL146341A0 (en) Pharmaceutical complex
GB9903784D0 (en) Pharmaceutical compounds
EG23946A (en) Novel pharmaceutical
IL145768A0 (en) Drinkable pharmaceutical solution
GB2373499B (en) Pharmaceutical compounds
GB9923933D0 (en) Novel pharmaceutical
GB0027081D0 (en) Solution
GB9923934D0 (en) Novel pharmaceutical
GB9926200D0 (en) Liquid purification
CA85983S (en) Pharmaceutical container
GB9926434D0 (en) Pharmaceutical
GB9926437D0 (en) Pharmaceutical
GB9912195D0 (en) Novel pharmaceutical
GB9912196D0 (en) Novel pharmaceutical
GB9912197D0 (en) Novel pharmaceutical
GB0015078D0 (en) Pharmaceutical solution